Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Recruiting 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Head & Neck 3

Conditions

Carcinoma, Non-Small-Cell Lung 10Prostatic Neoplasms 5Lung Neoplasms 5Breast Neoplasms 4Oropharyngeal Neoplasms 3Neoplasms 3Endometrial Neoplasms 3Stomach Neoplasms 2Rectal Neoplasms 2Pancreatic Neoplasms 2Urinary Bladder Neoplasms 1Ureteral Neoplasms 1Triple Negative Breast Neoplasms 1Thyroid Neoplasms 1Thyroid Diseases 1Stage I Mixed Cell Type Kidney Wilms Tumor 1Squamous Cell Carcinoma of Head and Neck 1Smoldering Multiple Myeloma 1Small Cell Lung Carcinoma 1Salivary Gland Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pneumonia 1Pleuropulmonary blastoma 1Pathologic Complete Response 1Paranasal Sinus Neoplasms 1Pancreatitis, Chronic 1Obesity 1Neurocognitive Disorders 1Neuroblastoma 1Neoplasm Metastasis 1

Interventions

Cisplatin 22Magnetic Resonance Spectroscopy 15Specimen Handling 13Platinum 12Radiotherapy, Intensity-Modulated 111,2-diaminocyclohexaneplatinum II citrate 11Radiotherapy 10Radiation 10Carboplatin 9Surveys and Questionnaires 5Biopsy 5pembrolizumab 4Taxes 4Paclitaxel 4Nivolumab 4Docetaxel 4Chemoradiotherapy 4Cetuximab 4Observation 3Fluorodeoxyglucose F18 3(225)Ac-DOTA-c(RGDyK) 3durvalumab 2X-Rays 2Watchful Waiting 2Standard of Care 2Radiotherapy, Image-Guided 2Interviews as Topic 2Immunoglobulin G 2Fluorouracil 2Disulfides 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Oropharyngeal Neoplasms × Observation × 90 days × Clear all
NCT03811015 2026-05-29

Testing Immunotherapy Versus Observation in Patients With HPV Throat Cancer

National Cancer Institute (NCI)

Phase 3 Active not recruiting
636 enrolled
Head & Neck

Oropharyngeal Neoplasms

NCT05541016 2026-05-12

De-Escalated Adjuvant and Definitive Radiation Therapy Informed by DART 2.0 ctHPV-DNA

Mayo Clinic

Phase 2 Recruiting
455 enrolled
Head & Neck

Carcinoma, Oropharyngeal Neoplasms

NCT07457099 2026-03-09

Impact of Postoperative Radiotherapy Versus PD-1 Inhibitor Maintenance on Survival in Resectable Locally Advanced Oral and Oropharyngeal Squamous Cell Carcinoma

Zhujiang Hospital

Not yet recruiting
85 enrolled
Head & Neck

Mouth Neoplasms, Oropharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡